Literature DB >> 24333253

Hsp65 phylogenetic assay for molecular diagnosis of nontuberculous mycobacteria isolated in Mexico.

Noé Escobar-Escamilla1, José Ernesto Ramírez-González1, Maribel González-Villa1, Pilar Torres-Mazadiego1, América Mandujano-Martínez1, Candelaria Barrón-Rivera2, Claudia Elena Bäcker2, David Esaú Fragoso-Fonseca1, Hiram Olivera-Díaz1, Patricia Alcántara-Pérez1, Alejandro Hernández-Solís3, Raúl Cícero-Sabido4, Iliana Alejandra Cortés-Ortíz5.   

Abstract

BACKGROUND AND AIMS: Nontuberculous mycobacteria (NTM) are mainly distributed as important emerging pathogens in patients with chronic or immunosuppressive diseases. Accurate identification of causative species is crucial for proper treatment and patient follow-up. However, several difficulties are associated with phenotypic and molecular diagnostic methods for precise identification at the species level due to shared metabolic and genetic characteristics. We undertook this study to evaluate the application of the phylogenetic method based on hsp65 gene into Telenti's PCR-restriction enzyme analysis (PRA) for molecular identification of NTM.
METHODS: The study population was comprised of 1646 Mycobacterium clinical isolates (AFB positive) collected from 2008-2011, of which 537 (32.6%) were MNT identified by PRA analysis. DNA sequencing of hsp65 in 53 isolates (10%) was performed. Sequence identification through NCBI-Basic Local Alignment Search Tool (BLAST) achieved correct identification in 23 isolates. Phylogenetic trees including hsp65 available GenBank sequences for all described genres of NTM and hsp65 obtained sequences were constructed using Mega 5.05 software. We compared sequence identification based on phylogenetic clustering and BLAST similarity search.
RESULTS: Phylogenetic clustering allowed more specific differentiation of closely related species and clearer identification in comparison with BLAST; 30 Mycobacterium species (this is the first report of isolation of some of these from clinical samples in Mexico) were identified in this way.
CONCLUSIONS: The proposed 440 bp hsp65 phylogenetic method allows a better identification tool to differentiate Mycobacterium species and is useful to complement diagnosis and epidemiological surveillance of NTM.
Copyright © 2014 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Molecular epidemiology; Nontuberculous mycobacteria; hsp65

Mesh:

Substances:

Year:  2013        PMID: 24333253     DOI: 10.1016/j.arcmed.2013.12.004

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  4 in total

1.  Prevalence of non-tuberculous mycobacteria among previously treated TB patients in the Gulf of Guinea, Africa.

Authors:  B D Thumamo Pokam; D Yeboah-Manu; S Ofori; P W Guemdjom; P M Teyim; L Lawson; D Amiteye; N Y Yhiler; I C Djuikoue; A E Asuquo
Journal:  IJID Reg       Date:  2022-05-14

2.  Direct matrix-assisted laser desorption ionisation time-of-flight mass spectrometry identification of mycobacteria from colonies.

Authors:  D Zingue; C Flaudrops; M Drancourt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-23       Impact factor: 3.267

3.  Isolation and Histopathological Changes Associated with Non-Tuberculous Mycobacteria in Lymph Nodes Condemned at a Bovine Slaughterhouse.

Authors:  Angélica M Hernández-Jarguín; Julio Martínez-Burnes; Gloria M Molina-Salinas; Ned I de la Cruz-Hernández; José L Palomares-Rangel; Alfonso López Mayagoitia; Hugo B Barrios-García
Journal:  Vet Sci       Date:  2020-11-10

4.  Nontuberculous mycobacteria in milk from positive cows in the intradermal comparative cervical tuberculin test: implications for human tuberculosis infections.

Authors:  Carmen Alicia Daza Bolaños; Marília Masello Junqueira Franco; Antonio Francisco Souza Filho; Cássia Yumi Ikuta; Edith Mariela Burbano-Rosero; José Soares Ferreira Neto; Marcos Bryan Heinemann; Rodrigo Garcia Motta; Carolina Lechinski de Paula; Amanda Bonalume Cordeiro de Morais; Simony Trevizan Guerra; Ana Carolina Alves; Fernando José Paganini Listoni; Márcio Garcia Ribeiro
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2018-02-15       Impact factor: 1.846

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.